In this issue:
- SWEDEPAD reopens paclitaxel safety discussion, finds drug-coated devices do not improve outcomes
- Opinion: “All patients need to be offered the chance to take part in a randomised controlled trial,” says Athanasios Saratzis (Leicester, UK)
- Closer to the goal: Shoring up data behind breakthrough imaging technology that plots a radiation-free future in new RCT
- In profile: Alik Farber (Boston, USA)
- Research highlights from the the 39th European Society for Vascular Surgery (ESVS) annual meeting (23–26 September, Istanbul, Türkiye)
